Sidney Kimmel Cancer Center at Thomas Jefferson University

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website

Clinical Trials

SEMS Placement Before Surgery in Unblocking Bile Duct in Patients With Periampullary Pancreatic Cancer With Severe Obstructive Jaundice

Not Applicable

Terminated

Conditions: Pancreatic Cancer

Interventions: Other: Standard of care
Procedure: Endoscopic Retrograde Cholangiopancreatography

First Posted Date: 2019-01-29

Last Posted Date: 2019-10-10

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 4

Registration Number: NCT03820544

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Decision Counseling Program in Increasing Shared Decision Making and Clinical Trial Participation in Patients With Stage 0-IV Lung Cancer (Free to Breathe)

Not Applicable

Completed

Conditions: Lung Cancer

Interventions: Other: Educational Intervention

First Posted Date: 2019-01-29

Last Posted Date: 2022-09-08

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 44

Registration Number: NCT03820557

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Evaluation and Management for Prostate Oncology, Wellness, and Risk (EMPOWeR)

Completed

Conditions: Prostate Cancer

First Posted Date: 2019-01-17

Last Posted Date: 2024-03-15

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 241

Registration Number: NCT03807492

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Linaclotide in Treating Patients With Stages 0-3 Colorectal Cancer

Phase 2

Active, not recruiting

Conditions: Stage 0 Colorectal Cancer AJCC v8
Stage I Colorectal Cancer AJCC v8
Stage IIB Colorectal Cancer AJCC v8
Stage IIIA Colorectal Cancer AJCC v8
Colorectal Adenoma
Stage II Colorectal Cancer AJCC v8
Stage IIC Colorectal Cancer AJCC v8
Stage IIIB Colorectal Cancer AJCC v8
Stage IIA Colorectal Cancer AJCC v8
Stage III Colorectal Cancer AJCC v8

Interventions: Other: Placebo
Drug: Linaclotide

First Posted Date: 2019-01-08

Last Posted Date: 2024-05-03

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 230

Registration Number: NCT03796884

Locations: 🇺🇸
VA Puget Sound Health Care Sysem, Seattle, Washington, United States
🇺🇸
Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma

Phase 2

Completed

Conditions: Uveal Melanoma

Interventions: Radiation: Stereotactic Body Radiation Therapy
Biological: Ziv-Aflibercept

First Posted Date: 2018-10-19

Last Posted Date: 2023-01-06

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 3

Registration Number: NCT03712904

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

Phase 2

Active, not recruiting

Conditions: Hematopoietic and Lymphoid Cell Neoplasm

Interventions: Radiation: Total-Body Irradiation
Procedure: Donor Lymphocyte Infusion
Drug: Cyclophosphamide
Procedure: Allogeneic Hematopoietic Stem Cell Transplantation
Drug: Tacrolimus
Drug: Mycophenolate Mofetil

First Posted Date: 2018-10-19

Last Posted Date: 2024-03-05

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 10

Registration Number: NCT03712878

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Durvalumab With or Without Metformin in Treating Participants With Head and Neck Squamous Cell Carcinoma

Early Phase 1

Completed

Conditions: Head and Neck Squamous Cell Carcinoma
Oral Cavity Squamous Cell Carcinoma
Oropharyngeal Squamous Cell Carcinoma

Interventions: Drug: Metformin
Biological: Durvalumab

First Posted Date: 2018-08-07

Last Posted Date: 2024-03-13

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 38

Registration Number: NCT03618654

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Vitamin B6 in Reducing Hot Flashes in Participants With Prostate Cancer Undergoing Antiandrogen Therapy

Not Applicable

Completed

Conditions: Hot Flashes
Prostate Carcinoma

Interventions: Dietary Supplement: Vitamin B6
Other: Questionnaire Administration

First Posted Date: 2018-07-09

Last Posted Date: 2024-12-12

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 43

Registration Number: NCT03580499

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

Early Phase 1

Completed

Conditions: Esophagus

Interventions: Procedure: Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA)
Procedure: Contrast-Enhanced Ultrasound
Procedure: Fine-Needle Aspiration
Drug: Sonazoid (Perflubutane)

First Posted Date: 2018-07-06

Last Posted Date: 2022-11-17

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 35

Registration Number: NCT03578224

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Remote Activity Monitored by Fitbit Charge 3 in Investigating Daily Step and Sleep Data in Participants With Head and Neck Cancer Undergoing Radiation Therapy

Not Applicable

Completed

Conditions: Head and Neck Carcinoma

Interventions: Device: Monitoring Device

First Posted Date: 2018-04-05

Last Posted Date: 2024-01-31

Lead Sponsor: Sidney Kimmel Cancer Center at Thomas Jefferson University

Target Recruit Count: 41

Registration Number: NCT03489252

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy